BCL2 and neoplasm: This is due to that fact that co-delivery of DOX and Bcl-2 siRNA produce a synergistic anti-tumor effect in which sensitivity of HepG2 cells to DOX was enhanced owing to down-regulation of BCL-2 by RNA interference.